Daiwa Securities Group Inc. Buys 1,106 Shares of Teleflex Incorporated (NYSE:TFX)

Daiwa Securities Group Inc. lifted its position in Teleflex Incorporated (NYSE:TFX) by 10.9% in the third quarter, according to its most recent Form 13F filing with the SEC. The firm owned 11,295 shares of the medical technology company’s stock after purchasing an additional 1,106 shares during the period. Daiwa Securities Group Inc.’s holdings in Teleflex were worth $2,793,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Tidal Investments LLC grew its position in shares of Teleflex by 214.7% during the 1st quarter. Tidal Investments LLC now owns 6,644 shares of the medical technology company’s stock worth $1,503,000 after buying an additional 4,533 shares in the last quarter. Boston Trust Walden Corp grew its holdings in Teleflex by 2.7% during the 2nd quarter. Boston Trust Walden Corp now owns 233,913 shares of the medical technology company’s stock worth $49,199,000 after acquiring an additional 6,076 shares in the last quarter. Assenagon Asset Management S.A. increased its position in Teleflex by 876.7% during the 2nd quarter. Assenagon Asset Management S.A. now owns 21,576 shares of the medical technology company’s stock valued at $4,538,000 after purchasing an additional 19,367 shares during the period. Simplify Asset Management Inc. purchased a new position in Teleflex during the 3rd quarter valued at about $4,800,000. Finally, Swedbank AB bought a new stake in shares of Teleflex in the 1st quarter valued at about $679,000. Institutional investors own 95.62% of the company’s stock.

Teleflex Price Performance

Shares of NYSE TFX opened at $192.00 on Thursday. Teleflex Incorporated has a fifty-two week low of $185.66 and a fifty-two week high of $257.85. The company has a market cap of $8.92 billion, a PE ratio of 38.17, a P/E/G ratio of 1.99 and a beta of 1.18. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.39 and a current ratio of 2.42. The business has a 50-day simple moving average of $221.96 and a two-hundred day simple moving average of $222.66.

Teleflex (NYSE:TFX) last released its earnings results on Thursday, October 31st. The medical technology company reported $3.49 EPS for the quarter, topping analysts’ consensus estimates of $3.38 by $0.11. Teleflex had a net margin of 7.85% and a return on equity of 14.19%. The company had revenue of $764.40 million during the quarter, compared to analysts’ expectations of $768.68 million. During the same period last year, the business earned $3.64 EPS. Teleflex’s revenue for the quarter was up 2.4% on a year-over-year basis. As a group, equities analysts expect that Teleflex Incorporated will post 13.98 EPS for the current fiscal year.

Teleflex Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Monday, December 16th. Investors of record on Friday, November 15th will be paid a $0.34 dividend. The ex-dividend date of this dividend is Friday, November 15th. This represents a $1.36 dividend on an annualized basis and a yield of 0.71%. Teleflex’s dividend payout ratio (DPR) is 27.04%.

Analyst Upgrades and Downgrades

TFX has been the topic of several research reports. Mizuho cut their price objective on shares of Teleflex from $275.00 to $250.00 and set a “neutral” rating on the stock in a report on Friday, November 1st. Royal Bank of Canada cut their price target on Teleflex from $275.00 to $245.00 and set an “outperform” rating on the stock in a report on Friday, November 1st. Stephens upped their price objective on Teleflex from $275.00 to $290.00 and gave the stock an “overweight” rating in a research note on Friday, August 2nd. StockNews.com upgraded Teleflex from a “hold” rating to a “buy” rating in a research note on Thursday. Finally, Truist Financial reissued a “hold” rating and set a $227.00 price target (down from $255.00) on shares of Teleflex in a research report on Monday, November 4th. Three equities research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. According to data from MarketBeat, Teleflex currently has a consensus rating of “Moderate Buy” and a consensus price target of $259.25.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.